Gen Z's preference for convenient formats like gummies and effervescent powders, coupled with rising health awareness, is ...

UBS analyst Colin White maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at p1,385.00. Don’t Miss TipRanks’ Hal ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target of £14.50. The company’s shares ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...

U.S. Senator Maggie Hassan has initiated an investigation into GlaxoSmithKline's decision to discontinue the Flovent HFA ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

Workshops, technical symposia, and the American Chemical Society signing the Stockholm Declaration on Chemistry for the ...

Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant ...

Senator Maggie Hassan launches an investigation into GlaxoSmithKline's withdrawal of a popular asthma inhaler, linking it to ...

Nifty clocks best weekly gain in last 6 weeks . Both Nifty and Sensex gain 2% for the week led by financial services . Nifty ...

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...